摘要
目的观察头孢地嗪、痰热清注射液治疗小儿肺炎的疗效及用药安全性。方法将106例小儿肺炎患者随机分为试验组53例和对照组53例。治疗组采用头孢地嗪和痰热清注射液(上海凯宝药业生产,主要成分为黄芩、熊胆粉、山羊角、金银花、连翘)联合用药,与单独用头孢地嗪进行疗效比对,观察平均住院日,治疗过程中体温、白细胞计数、氧合指数及呼吸道感染评分结果。结果试验组患儿体温和白细胞数于第4治疗日较对照组均有明显下降(P<0.05);氧合指数以及呼吸道感染评分的改善于治疗第7日后明显优于对照组(P<0.05)。结论头孢地嗪联合痰热清用药治疗小儿肺炎,效果明显优于单独头孢地嗪用药,可显著减轻病情,缩短病程。
Objective To observe the clinical efficacy and safety of cefodizime combined with Tanreqing Injec- tion in the treatment of child pneumonia. Methods 106 children patients with acute pneumonia were randomly divid- ed into the control group and the treatment group,53 cases in each group. The treatment group adopted the combined medication of cefodizime and Tanreqing Injection（including the main components of Radix Scutellariae, Bear gall pow- der,goat horn,Lonicera japonica and Fructus forsythiae）, while the control group was given cefodizime alone. Then the clinical efficacies were compared between the two groups. The average hospitalization duration,and body tempera- ture,leukocyte count, oxygenation index and respiratory infection score results during treatment process were ob- served. Results The body temperature and WBC count on 4 d after treatment in the treatment group were signifi- cantly decreased compared with the control group（P〈0.05）. The improvement of the oxygenation index and respira- tory infection score on 7 d after treatment were obviously superior to the control group（P〈0.05）. Conclusion Cefo- dizime combined with Tanreqing Injection has more significant effect than single cefodizime, which can significantly alleviate the illness condition and shorten the disease course.
出处
《检验医学与临床》
CAS
2013年第6期687-688,共2页
Laboratory Medicine and Clinic
关键词
头孢地嗪
痰热清
肺炎
cefodizime
Tanreqing Injection
pneumonia
